Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.39M Sell
18,631
-1,151
-6% -$135K 0.05% 177
2026
Q1
$2.38M Sell
19,782
-1,419
-7% -$164K 0.07% 158
2025
Q4
$2.23M Sell
21,201
-260
-1% -$24.4K 0.06% 176
2025
Q3
$1.8M Sell
21,461
-2,975
-12% -$245K 0.05% 205
2025
Q2
$1.93M Buy
24,436
+2,535
+12% +$202K 0.06% 188
2025
Q1
$1.97M Buy
21,901
+968
+5% +$90.4K 0.07% 164
2024
Q4
$2.08M Buy
+20,933
New +$2.16M 0.06% 155

Other funds holding MRK

SBI Securities's MRK Position: Q2 2026 in Review

SBI Securities reduced its Merck (MRK) stake by 5.8% in Q2 2026, selling an estimated $135K and leaving 18,631 shares worth $2.39M. The position accounts for 0.05% of the portfolio, ranked #177.

SBI Securities first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • SBI Securities held 18,631 shares of Merck worth $2.39M as of Q2 2026.
  • SBI Securities sold 1,151 Merck shares in Q2 2026, an estimated $135K.
  • Merck made up 0.05% of SBI Securities's portfolio in Q2 2026, its #177 holding.
  • SBI Securities first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.